Spero Therapeutics (SPRO) Preferred Dividend Payments (2016 - 2017)
Spero Therapeutics (SPRO) reported Preferred Dividend Payments of $833000.0 for Q4 2017, down 9.26% on a YoY basis from $918000.0 in Q4 2016, and down 59.41% quarter-over-quarter from $2.1 million in Q3 2017.
Spero Therapeutics (SPRO) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Spero Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at $833000.0 in Q4 2017.
- For the quarter ending Q4 2017, Preferred Dividend Payments fell 9.26% year-over-year to $833000.0; the trailing twelve-month figure through Dec 2017 stood at $6.1 million (changed N/A YoY), and the FY2017 full-year result was $6.1 million, up 78.61% from the prior year.
- Preferred Dividend Payments for Q4 2017 stood at $833000.0, down from $2.1 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $2.1 million in Q3 2017, with the low at $833000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Spero Therapeutics | 129.74 Mn | 73.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 833,000.00 |
| Sep 30, 2017 | 2.05 Mn |
| Jun 30, 2017 | 2.03 Mn |
| Mar 31, 2017 | 1.24 Mn |
| Dec 31, 2016 | 918,000.00 |
| Sep 30, 2016 | 916,000.00 |